Filing Details
- Accession Number:
- 0001140361-15-004238
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-05 12:12:03
- Reporting Period:
- 2015-02-03
- Filing Date:
- 2015-02-05
- Accepted Time:
- 2015-02-05 12:12:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1184156 | Thomas Craig | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-03 | 1,500 | $56.95 | 13,984 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-03 | 1,000 | $157.05 | 12,984 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-03 | 500 | $157.71 | 12,484 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-02-04 | 700 | $56.95 | 13,184 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-04 | 700 | $156.50 | 12,484 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option | Disposition | 2015-02-03 | 1,500 | $0.00 | 1,500 | $56.95 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2015-02-04 | 700 | $0.00 | 700 | $56.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,434 | 2015-02-13 | No | 4 | M | Direct | |
| 734 | 2015-02-13 | No | 4 | M | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $156.50 to $157.40, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $157.52 to $157.91, inclusive.
- Grant of options to buy shares of common stock that vested on 02/14/2009.
Billionaire Hedge Funds
